Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Innovation Fund Boosts Commercialization of Purdue Technologies

Published: Thursday, January 31, 2013
Last Updated: Thursday, January 31, 2013
Bookmark and Share
Purdue University innovations in research areas including personal health monitoring, advanced diabetes treatment and energy-efficient metal sheet processing, received more than $260,000 in the most recent round of awards through the Trask Innovation Fund.

The Purdue Research Foundation-managed Trask Innovation Fund is a technology development program to assist faculty who have disclosed a discovery to the Purdue Office of Technology Commercialization.

"The Trask Innovation Fund provides critical financial support to Purdue researchers who have patented a technology but need to develop a prototype or finalize research data that supports the discovery’s move to the public," said Joseph B. Hornett, senior vice president, treasurer and COO of the Purdue Research Foundation.

The 10-member Trask Innovation Advisory Council is composed of external business executives and representatives from the Purdue Research Foundation, Purdue University Office of the Vice President for Research and Purdue faculty researchers.

"The process is competitive and the recipients must demonstrate how the discovery will meet a public need, how soon the technology can be commercialized, and how the Trask funds will help the researcher advance its development," said Richard O. Buckius, Purdue's vice president for research and co-director of the Trask Advisory Council.

Project managers from the Purdue Office of Technology Commercialization collaborate with Purdue researchers to move their discoveries through the patent and commercialization process.

"One of our primary goals is to encourage and support the development of new products that have commercial potential," said Elizabeth Hart-Wells, assistant vice president of the Purdue Office of Technology Commercialization and co-director of the Trask Advisory Council. "Each of our project managers is specialized in a specific discipline, and they work directly with researchers to protect Purdue’s intellectual property, and to translate and ultimately license a new technology to appropriate industry partners."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Friday, April 22, 2016
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!